For the prophylaxis of organ rejection in patients receiving allogenic liver or kidney transplant and for the treatment of lupus nephritis
Place of Origin
Ireland
Product Usage
In two divided doses, every 12 hours
- Adult kidney transplant patients in combination with azathioprine: Recommended Initial Oral Dosage : 0.2 mg/kg/day
- Adult kidney transplant patients in combination with MMF/IL-2 receptor antagonist : Recommended Initial Oral Dosage : 0.1 mg/kg/day
- Adult liver transplant patients : Recommended Initial Oral Dosage : 0.10-0.15 mg/kg/day
- Pediatric liver transplant patients : Recommended Initial Oral Dosage : 0.15-0.20 mg/kg/day
Ingredients
Active Ingredient: tacrolimus
Other Ingredients: hydroxypropryl methylcellulose, croscarmellose sodium, lactose monoydrate, and magnesium stearate
Warnings
Prograf is contraindicated in patients with a hypersensitivity to tacrolimus.
WARNING
Increased susceptibility to infection and the possible development of lymphoma may result from immunosuppression. Only physicians experienced in immunosuppressive therapy and management of organ transplant patients should prescribe Prograf. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.
For patients with lupus nephritis
Width
1
Height
1
Depth
1